EUVIMEDEUVIMED entdecken
Crossref

Targeting Cancer Cells With Co(III)‐Bipyridyl Complex: A Combined In Vitro and In Silico Study on U87MG and ME‐180 Cell Lines

Shabnam Sultana, Tithi Maity iD, Pronab Kundu, D Sravanakumar Perumalla, Manik Das, Ennio Zangrando iD, Sresha Sarkar, Srinu Tothadi, Mousumi Giri, Shreya Jana, Susmita Mondal iD, Ria Sanyal iD

Chemistry & Biodiversity · 2026-06 · 23 (6)

DOI: 10.1002/cbdv.71370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 30.05.2026. Verfasst von Shabnam Sultana und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Diamond Harbour Women's University, Sarisha, West Bengal, India. Hauptthemen laut MEDLINE: Cobalt, Antineoplastic Agents, Coordination Complexes, 2,2'-Dipyridyl. Die Arbeit nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although some Co‐bipyridyl systems have been explored in anticancer research, further enhancement in the therapeutic index of mixed‐ligand polypyridyl Co III ‐centered compounds is a prime necessity. In this work, a new octahedral cobalt(III) complex, [Co III (Me 2 bpy) 2 (N 3 ) 2 ] + , featuring 5,5'‐dimethyl‐2,2'‐bipyridyl (Me 2 bpy) and coordinated terminal azide ligands, was synthesized and characterized using single crystal x‐ray diffraction and spectroscopic techniques. Density functional theory (DFT) calculations provided insights into the metal–ligand bonding and electronic transitions. Biophysical studies, complemented by molecular docking with calf thymus DNA (ct‐DNA) and human serum albumin (HSA) suggested a strong interaction between the Co III complex and ct‐DNA. In silico toxicological studies demonstrate a safer toxicity profile of Co III complex than paclitaxel, a clinically approved anticancer drug and comparable to Doxovir, a gold‐standard in biologically active Co III ‐species. In vitro MTT assay showed that the Co III complex is more cytotoxic to glioblastoma multiforme (U87MG; IC 50 = 29.9 µM) and human cervical cancer cells (ME‐180; IC 50 = 11 µM) than its controls in a dose‐dependent and apoptotic pathway, with cervical carcinoma cells appearing more susceptible to Co III ‐mediated effects. The results demonstrate that Co III complex significantly enhances the therapeutic potential of paclitaxel through synergistic cytotoxic and antimigratory effects, underscoring its promise as a chemo adjuvant candidate for combinatorial cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CobaltAntineoplastic AgentsCoordination Complexes2,2'-DipyridylHumansMolecular Docking SimulationDrug Screening Assays, AntitumorDNAApoptosisCell Line, TumorCell ProliferationAnimalsSerum Albumin, HumanDensity Functional TheoryStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

DNA bindinganticancer activitychemo adjuvant therapycobalt(III) complexmolecular dockingprotein binding

Substanzen

CobaltAntineoplastic AgentsCoordination Complexes2,2'-DipyridylDNAcalf thymus DNASerum Albumin, Human

Autor:innen und Institutionen

  • Department of Chemistry, Diamond Harbour Women's University, Sarisha, West Bengal, India.
  • Department of Chemistry, Natural Science Research Center, Prabhat Kumar College (Vidyasagar University), Contai, West Bengal, India.
  • Department of Chemistry, Presidency University, Bengaluru, Karnataka, India.
  • Department of Applied Sciences and Humanities, Sasi Institute of Technology & Engineering, Tadepalligudem, Andhra Pradesh, India.
  • Department of Chemistry, Jadavpur University, Kolkata, West Bengal, India.
  • Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.

ORCID-Profile: Tithi Maity, Ennio Zangrando, Susmita Mondal, Ria Sanyal

Zitieren

APA

Sultana, S., Maity, T., Kundu, P., Perumalla, D. S., Das, M., Zangrando, E., Sarkar, S., Tothadi, S., Giri, M., Jana, S., Mondal, S., & Sanyal, R. (2026). Targeting Cancer Cells With Co(III)‐Bipyridyl Complex: A Combined In Vitro and In Silico Study on U87MG and ME‐180 Cell Lines. Chemistry & Biodiversity, 23(6). https://doi.org/10.1002/cbdv.71370

Vancouver

Sultana S, Maity T, Kundu P, Perumalla DS, Das M, Zangrando E, et al. Targeting Cancer Cells With Co(III)‐Bipyridyl Complex: A Combined In Vitro and In Silico Study on U87MG and ME‐180 Cell Lines. Chemistry & Biodiversity. 2026;23(6). doi:10.1002/cbdv.71370

BibTeX
@article{Sultana2026,
  author = {Sultana, Shabnam and Maity, Tithi and Kundu, Pronab and Perumalla, D Sravanakumar and Das, Manik and Zangrando, Ennio and Sarkar, Sresha and Tothadi, Srinu and Giri, Mousumi and Jana, Shreya and Mondal, Susmita and Sanyal, Ria},
  title = {Targeting Cancer Cells With Co(III)‐Bipyridyl Complex: A Combined In Vitro and In Silico Study on U87MG and ME‐180 Cell Lines},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {6},
  doi = {10.1002/cbdv.71370}
}
Kostenlos starten →